Skip to main content
Year archive

AROVELLA THERAPEUTICS LIMITED — 2018 filings

All 70 regulatory filings released by AROVELLA THERAPEUTICS LIMITED (ALA) in 2018, sourced directly from the official regulator.

70 Filings
2018 Period
2018 filings (70)
Filing Released Lang
SUDA Signs Agreement With Mitsubishi Tanabe 3 pages 155.4KB
Capital/Financing Update
2018-12-18 English
SUDA Enters Agreement To Develop Cannabinoid Spray 3 pages 155.6KB
Capital/Financing Update
2018-12-05 English
ZLD: ZLD to Invest in Development of Oral Spray Formulations 2 pages 176.1KB
Capital/Financing Update
2018-12-05 English
SUDA Receives R&D Tax Incentive Refund 1 page 133.6
Capital/Financing Update
2018-11-14 English
AGM Presentation 15 pages 790.7KB
AGM Information
2018-11-14 English
Results of Meeting 2 pages 608.1KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-14 English
ZolpiMist Market Update 3 pages 125.1KB
Capital/Financing Update
2018-11-12 English
Anagrelide Paper By SUDA Scientific Board Member 4 pages 513.4KB
Regulatory Filings
2018-11-11 English
Strides Press Release 4 pages 396.7KB
Capital/Financing Update
2018-11-08 English
SUDA Signs Agreement For SUD-001H For US Market 3 pages 158.8KB
Capital/Financing Update
2018-11-07 English
Boardroom Radio Broadcast 1 page 132.0KB
Investor Presentation
2018-11-07 English
Trading Halt 2 pages 498.2KB
Regulatory Filings
2018-11-06 English
Appendix 4C, Market Update and Top 20 9 pages 469.2KB
Interim / Quarterly Report Q1 2019
2018-10-28 English
Pause in Trading 1 page 112.1KB
Regulatory Filings
2018-10-16 English
Suspension from Official Quotation 1 page 217.4KB
Delisting Announcement
2018-10-16 English
Response to ASX Price Query 4 pages 447.0KB
Regulatory Filings
2018-10-16 English
Reinstatement to Official Quotation 1 page 217.2KB
Regulatory Filings
2018-10-16 English
Notice of Annual General Meeting/Proxy Form 14 pages 438.0KB
AGM Information
2018-10-11 English
SUDA Appoints Business Development VP In The USA 2 pages 135.3KB
Board/Management Information
2018-10-10 English
Appendix 4G and Corporate Governance Statement 23 pages 501.2KB
Governance Information
2018-09-27 English
Annual Report to shareholders 88 pages 3.8MB
Annual Report FY 2018
2018-09-27 English
Market Update 3 pages 137.9KB
Capital/Financing Update
2018-09-11 English
Pause in Trading 1 page 111.7KB
Regulatory Filings
2018-09-10 English
Trading Halt 1 page 214.7KB
Regulatory Filings
2018-09-10 English
Request for Trading Halt 1 page 122.4KB
Regulatory Filings
2018-09-10 English
SUDA Accredited As An Australian Trusted Trader 1 p
Regulatory Filings
2018-09-09 English
SUDA Expands Scientific Advisory Board For Anagrelide 3 pages 140.4KB
Board/Management Information
2018-09-05 English
Preliminary Final Report 12 pages 169.3KB
Annual Report FY 2018
2018-08-30 English
Investor Presentation 25 pages 1.3MB
Investor Presentation
2018-08-27 English
SUDA Expands Patent Coverage For Sildenafil Sprays 2 pages 140.6KB
Capital/Financing Update
2018-08-21 English
SUDA Achieves TGA GMP Licence 2 pages 132.6KB
Regulatory Filings
2018-08-20 English
Top 20 securityholders 2 pages 129.8KB
Major Shareholding Notification
2018-08-13 English
Change of Directors' Interest Notice 6 pages 184.0KB
Director's Dealing
2018-08-02 English
Rights Issue and Placement Completed and Appendix 3B 14 pages 451.7KB
Capital/Financing Update
2018-08-01 English
Change of Director's Interest Notice 6 pages 199.2KB
Director's Dealing
2018-07-30 English
Appendix 4C - quarterly 6 pages 290.7KB
Interim / Quarterly Report Q4 2018
2018-07-30 English
Supplementary Prospectus 2 pages 62.1KB
Capital/Financing Update
2018-07-30 English
Rights Issue Closes Significantly Oversubscribed 2 pages 154.4KB
Capital/Financing Update
2018-07-30 English
David Phillips To Lead Business Development 2 pages 135.4KB
Board/Management Information
2018-07-24 English
Corporate Presentation 25 pages 2.7MB
Investor Presentation
2018-07-16 English
Business Development Update 2 pages 146.3KB
Capital/Financing Update
2018-07-15 English
ASX Waiver To Grant Secured Convertible Notes 4 pages 146.2KB
Capital/Financing Update
2018-07-15 English
Anagrelide Update 2 pages 666.1KB
Capital/Financing Update
2018-07-11 English
Settlement with HC Berlin Pharma and Rights Issue 5 pages 193.0KB
Capital/Financing Update
2018-07-01 English
Appendix 3B 13 pages 319.7KB
Capital/Financing Update
2018-07-01 English
Prospectus for a Renounceable Pro Rata Offer 46 pages 1.4MB
Capital/Financing Update
2018-07-01 English
Letter to Eligible Shareholders 3 pages 94.5KB
Capital/Financing Update
2018-07-01 English
Letter to Ineligible Shareholders 1 page 85.6KB
Capital/Financing Update
2018-07-01 English
Trading Halt 2 pages 153.9KB
Regulatory Filings
2018-06-27 English
Shareholder Update 4 pages 168.2KB
Capital/Financing Update
2018-06-20 English
SUDA Expands Patent Coverage For Sildenafil 2 pages 140.8KB
Regulatory Filings
2018-06-17 English
SUDA announces update on ZolpiMist in USA and Canada 2 pages 657.5KB
Capital/Financing Update
2018-06-14 English
SUDA Establishes Scientific Advisory Board 2 pages 580.1KB
Regulatory Filings
2018-05-14 English
Shareholder update 3 pages 610.0KB
Capital/Financing Update
2018-05-08 English
SUDA expands dialogue with World Health Organisation 2 pages 592.8KB
Regulatory Filings
2018-05-06 English
HC Berlin Pharma Update 1 page 130.4KB
Regulatory Filings
2018-05-03 English
HC Berlin Pharma Update 1 page 130.6KB
Regulatory Filings
2018-04-30 English
Appendix 4C - quarterly 7 pages 294.3KB
Interim / Quarterly Report Q3 2018
2018-04-29 English
Final Director's Interest Notice 3 pages 226.1KB
Director's Dealing
2018-04-10 English
SUDA Announces Resignation of Michael Stewart 2 pages 134.2KB
Board/Management Information
2018-04-09 English
SUDA Appoints David Phillips To The Board 2 pages 138.5KB
Board/Management Information
2018-04-08 English
Initial Director's Interest Notice 2 pages 119.7KB
Director's Dealing
2018-04-08 English
Appendix 3B 14 pages 403.6KB
Capital/Financing Update
2018-04-04 English
HC Berlin Pharma Update 2 pages 133.2KB
Regulatory Filings
2018-03-28 English
SUDA Completes Divestment of Subsidiary 2 pages 390.4KB
Capital/Financing Update
2018-03-07 English
Half Yearly Report and Accounts 22 pages 491.7KB
Interim / Quarterly Report H1 2018
2018-02-27 English
Divestment Of Non-Core Subsidiary 2 pages 111.4KB
Capital/Financing Update
2018-02-26 English
New Analyst Report 2 pages 130.7KB
Regulatory Filings
2018-02-15 English
Appendix 4C - quarterly 7 pages 815.6KB
Interim / Quarterly Report Q2 2018
2018-01-30 English
SUDA Completes Acquisition Of Anti-Cancer Agent 2 pages 408.2KB
Capital/Financing Update
2018-01-23 English